Back to Search
Start Over
B-Cell Non-Hodgkin Lymphoma Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies
- Source :
- M2 Presswire. February 18, 2025
- Publication Year :
- 2025
-
Abstract
- M2 PRESSWIRE-February 18, 2025-: B-Cell Non-Hodgkin Lymphoma Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies (C)1994-2025 M2 COMMUNICATIONS RDATE:17022025 DelveInsight's, 'B-Cell Non-Hodgkin [...]
- Subjects :
- Novartis Pharma AG -- Product development
Reports
Product development
Non-Hodgkin lymphomas -- Reports
Clinical trials -- Reports
Business research -- Reports
Atezolizumab -- Product development
Nivolumab -- Reports
Medical research -- Reports
Obinutuzumab -- Reports
Drug approval -- Reports
Antineoplastic agents -- Product development
Tisagenlecleucel -- Product development
Business -- Research
Medicine, Experimental -- Reports
Non-Hodgkin's lymphomas -- Reports
Antimitotic agents -- Product development
Subjects
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- M2 Presswire
- Publication Type :
- News
- Accession number :
- edsgcl.827820317